https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811


https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811


https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811

The global assisted reproductive technology (ART) market was valued at USD 21.32 billion in
2018 and is projected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8% during
the forecast period. In 2018, Europe led the global market with a share of 41.18%.
Assisted reproductive technologies, also known as assisted reproductive treatments, include
various techniques used to address infertility. These treatments encompass a wide range of
procedures tailored to the specific causes of infertility.
For More Information, Visit – https://www.fortunebusinessinsights.com/industry-
reports/assisted-reproductive-technology-art-market-101811
Top Companies in the ART Market
 Bloom IVF Centre
 California Cryobank
 CARE Fertility
 Monash IVF Group
 Carolinas Fertility Institute
 European Sperm Bank

INVO Bioscience
 Apollo Hospitals Enterprise Ltd.
Key Industry Development
In August 2018, GI Partners made a significant move by acquiring California Cryobank (CCB)
and Cord Blood Registry (CBR) to strengthen its position in the stem cell storage and
reproductive tissue services markets. This acquisition has enabled the company to expand its
footprint in the ART (Assisted Reproductive Technology) industry, offering advanced solutions
for fertility treatments, stem cell preservation, and reproductive health services globally. By
integrating CCB and CBR's established expertise, GI Partners aims to meet the growing demand
for innovative fertility and reproductive tissue services.
Market Drivers & Restraints
Market Drivers
 Rising Infertility Rates: The global rise in infertility cases, attributed to factors such as
delayed pregnancies, lifestyle changes, and environmental influences, is one of the
primary drivers for the ART market.
 Technological Advancements in Fertility Treatments: Innovations in IVF, genetic
screening, and embryo cryopreservation technologies are enhancing success rates and
driving the adoption of ART procedures.
 Increased Awareness and Acceptance: As societal acceptance of ART continues to
grow, more individuals and couples are opting for assisted reproduction to achieve their
parenthood goals.
 Government Support and Initiatives: Governments worldwide are providing support
through funding and policy reforms to promote fertility treatments, making ART more
accessible to a larger population.
Market Restraints
 High Treatment Costs: The significant cost of ART treatments, including IVF, egg
retrieval, and genetic testing, limits its accessibility, particularly in developing regions.
 Ethical and Regulatory Concerns: The regulation of ART practices and the ethical
challenges surrounding reproductive technologies, including the use of donor sperm and
egg, continue to hinder market expansion in certain regions.
 Complexity of Procedures: ART procedures, though effective, require highly
specialized care, which can be a barrier for patients who do not have easy access to
fertility clinics or medical professionals with the necessary expertise.
Market Report Coverage
The market report on Assisted Reproductive Technology (ART) provides a comprehensive
overview of the current market landscape, key players, trends, and forecasts. It covers the
following areas:
 Current market size and future growth projections
 Analysis of various ART procedures, including IVF, IUI, egg/sperm donation, and
genetic screening
 Technological innovations and their impact on fertility treatments
 Market segmentation based on procedure type, end-user, and geography
 Key developments and partnerships within the industry
Market Competitive Landscape
The competitive landscape of the ART market is dynamic, with both established players and new
entrants aiming to meet the growing demand for fertility treatments. Companies like Bloom IVF
Centre, CARE Fertility, and Monash IVF Group are leading the market by offering
comprehensive fertility services, including advanced IVF procedures, sperm and egg donation
programs, and genetic counseling. The recent acquisition of California Cryobank by GI Partners
has further intensified competition, positioning the company as a key player in the ART industry
with a diversified service offering spanning stem cell storage and reproductive tissue services.
Market Segments
The ART market is segmented into several categories based on the procedure types and end-
users:
 Fertility Procedures: This includes IVF, IUI (Intrauterine Insemination), egg/sperm
donation, cryopreservation, and genetic screening.

https://www.fortunebusinessinsights.com/checkout-page/101811

 End-Users: The end-users of ART services include fertility clinics, hospitals, and sperm
banks.
The fertility procedures segment is expected to dominate the market due to the increasing
preference for IVF and genetic testing, which are becoming more accessible and affordable.
Market Regional Insights
The ART market exhibits significant regional variations, with North America and Europe
leading in terms of market share due to advanced healthcare infrastructure, increased awareness,
and high demand for ART procedures. In these regions, ART services are widely available, and
there is strong government support for fertility treatments.
 North America: The North American ART market is expected to remain dominant due
to high treatment success rates, advanced medical technology, and an increasing number
of infertility cases.
 Europe: Europe is another key region with high market penetration, supported by well-
established fertility centers and favorable healthcare policies.
 Asia-Pacific: The Asia-Pacific region is poised for rapid growth, driven by rising
disposable incomes, increased healthcare investments, and improving healthcare
accessibility in countries like India and China.
Future Market Scope
The ART market is expected to grow significantly in the coming years, driven by continuous
advancements in reproductive medicine, increased affordability, and wider acceptance of ART
procedures globally. Emerging markets in Asia-Pacific and Latin America are anticipated to see
high demand due to improving healthcare infrastructure and a growing middle-class population.
The integration of artificial intelligence and genetic screening technologies will further boost the
market’s growth by enhancing the success rates of ART treatments and reducing the time and
cost associated with fertility procedures.
Purchase Full Report at : https://www.fortunebusinessinsights.com/checkout-page/101811
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative solutions for our clients,
assisting them address challenges distinct to their businesses. Our goal is to empower our clients
with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies
achieve sustainable growth. Our team of experienced analysts and consultants use industry-
leading research tools and techniques to compile comprehensive market studies, interspersed
with relevant data.